Toggle Offcanvas
...
 
Everolimus Tenders

Everolimus Tenders

View Everolimus tenders, RFPs and contracts. Bid on readily available Everolimus tenders with the best and most comprehensive tendering platform, since 2002.
Everolimus is an mTOR inhibitor primarily used in cancer treatment and organ transplantation. It helps slow tumor growth and prevents organ rejection by suppressing the immune system.

Bidding for Everolimus tenders is extremely lucrative for companies of all sizes. Tendering authorities and private companies release thousands of contracts worth millions for procurement of Everolimus.

Global Tenders stands out as the largest platform dedicated to pharmaceutical tenders and government contracts. Boasting over 20 years of experience in the tender business, GlobalTenders offers the most extensive and reliable Tenders/RFPs/Contracts Database available. The platform aggregates contracts from both public and private sources, connecting with a vast network of over half a million buyers. Employing advanced artificial intelligence, our meticulous process involves gathering information from over a hundred thousand sources. The data is then intelligently categorized into thousands of subcategories for easy filtering and presenting it in a user-friendly format for quick comprehension.

In addition to tender information, we offer in-depth Everolimus market analysis, bid consultancy services, and insights into top bidders and winners.

Sign up now to get instant access to unlimited Everolimus tenders, advanced search filters, market analysis, industry trends, tender training and 24/7 customer support.

22 Live Notices for Everolimus Tenders

Showing 1 to 20

Specific Multilot Contract, Pursuant To Art. 55 Of Legislative Decree No. 50/2016 And Ss.Mm.Ii., For The Supply Of Connected Drugs And Services
country Italy
posting date13 Jun 2025
deadline03 Jul 2025
Insulin Supply Glargina (Doe), Gadoteric Acid (Doe), Gadobutrol (Doe), Alpha 1 Antitripsin (Doe), Everolimus (Doe) And Arsenic Trioxide (Doe)
country Spain
posting date12 Jun 2025
deadline26 Jun 2025
Procurement Of Medical Aids, Medical Consumables For Interventional Cardiology-Stents And Distal Protection
country North Macedonia
posting date05 Jun 2025
deadline23 Jun 2025
Successive Supply Of Coronary Stents To The Health Areas Of: A Coruña And Cee; Santiago De Compostela And Barbanza; Lugo, Mariña And Monforte De Lemos; Vigo And Pontevedra And O Salnés
country Spain
posting date05 Jun 2025
deadline07 Jul 2025
Everolimus 10 Mg Cmcm Rec 1000021320
country Chile
posting date03 Jun 2025
deadline03 Jul 2025
Pharmaceutical Contracts With Accession Option
country Germany
posting date13 Feb 2025
deadline01 Feb 2027
Tender For Securing And Supplying Devices With Solutions And Consumables For Toxicology Laboratories Based On The Fixed Value System For Each Confirmed Result (Gpprr)
country Saudi Arabia
posting date05 Feb 2025
deadline02 Nov 2025
Tender For Securing And Supplying Devices With Solutions And Consumables For Toxicology Laboratories Based On The Fixed Value System For Each Confirmed Result (Gpprr)
country Saudi Arabia
posting date06 Jan 2025
deadline02 Nov 2025
Open House Discount Agreements 2024-03 - Everolimus (Atc: L04Ah02; Tab)
country Germany
posting date15 Feb 2024
deadline31 Oct 2026
Conclusion Of A Non-Exclusive Discount Agreement In Accordance With Section 130A Paragraph 8 Sgb V For The Active Ingredient Everolimus, Atc L04Aa18 For The Period February 1St, 2024 - January 31St, 2026
country Germany
posting date18 Dec 2023
deadline05 Dec 2025
Medicines With The Active Ingredient Everolimus (Atc: L04Aa18)
country Germany
posting date12 Dec 2023
deadline30 Nov 2025
Conclusion Of Non-Exclusive Discount Agreements In Accordance With Sections 130A Paragraph 8/130C Paragraph 1 Sgb V For Medicines With The Active Ingredient Everolimus (L04Aa18) As Part Of A So-Called Open House Model.
country Germany
posting date11 Oct 2023
deadline30 Sep 2025
Conclusion Of Non-Exclusive Discount Agreements In Accordance With Sections 130A Paragraph 8/130C Paragraph 1 Sgb V For Drugs With The Active Ingredient Everolimus (L04Aa18) As Part Of A So-Called Open House Model.
country Germany
posting date10 Oct 2023
deadline30 Sep 2025
Everolimus Drug Elluting Stent Of 50 Micron Strut Thickness With Biodegradable Polymer Hybrid Cell Quantity: 150
country India
posting date19 Jun 2025
deadline11 Jul 2025
Ethambutol 800 Mg Tab,Everolimus 0.25 Mg Tab,Everolimus 0.5 Mg Tab,Fentanyl 50 Mcg Transdermal Patc Quantity: 7540
country India
posting date18 Jun 2025
deadline09 Jul 2025
Everolimus 0.5 Mg Tab
country India
posting date14 Jun 2025
deadline23 Jun 2025
Tab. Everolimus 0.5 Mg
country India
posting date11 Jun 2025
deadline23 Jun 2025
Drug Eluting Stent - Everolimus Drug On Cobalt Chromium Platform With Ultra-Thin Struts Not More Than 60 Microns Open Ce.
country India
posting date06 Jun 2025
deadline19 Jun 2025
Salmeterol 50 Mcgfluticasone 250 Mcgmulti Dose Drypowder Nhaler Of 60 Dosesaccuhaler , Tadalafil 20 Mg Tab ,Aceclofenac 100 Mg Tab , Nicorandil 5Mg Tab ,Azelnidipine 8 Mg Tab , Rifaximin 400 Mg Tab , Carboxymethyl Cellulose Sodium Eye Drops 0 5 Percent 10 Ml, Everolimus 5 Mg Tab , Betaxolol Eye Drops 0 25Percent 0 5 Percent Bott Of 5 Ml , Insulin Highlypurified Isophane Human Nph 40 Iu Ml 10 Ml Inj ,Lacosamide 50 Mg Tab , Lacosamide 100 Mg Tab ,Metoprolol 12 5Mg Xl Tab Quantity: 327612
country India
posting date03 Jun 2025
deadline24 Jun 2025
Inj Sybrava 284 Mg , Lenvatinib 4 Mg Cap , Injenoxaparin Sodium 40 Mg , Everolimus 10 Mg Tab ,Abiraterone 500 Mg Tab , Capecitabine 500Mg Tab ,Megesterol Acetate 40 Mg , Cabozantinib 20 Mg Tab ,Vericiguat 10 Mg Tab , Inj Secukinumab 150 Mg ,Ribociclib 200 Mg Tab , Acalabrutinib 100 Mg ,Ruxolitinib 5Mg Tab , Daratumunab 1200 Mg Inj , Injepoetin Alfa 75 Mg Mircera , Dry Laser Film 8 X 10Compatable With Dry Pix 6000 Fugi Film Cartidge Of150 Films Each , Dry Laser Film 10 X 12 Compatablewith Dry Pix 6000 Fugi Film Cartidge Of 150 Filmseach , Inj Heparin 25000 Iu , Hemoflow F6 , Tubing Setfor Hemodialysis , Daratumunab 600 Mg Inj , Injfilgrastim 300 Mcg , Inj Denosumab 60 Mg Quantity: 2019
country India
posting date31 May 2025
deadline20 Jun 2025

Share Share this page